EKF Diagnostics Holdings (LSE:EKF) Cash Flow for Dividends: £0.00 Mil (TTM As of Dec. 2025)


LSE:EKF EKF Diagnostics Holdings PLC LSE:EKF
54 GF Score
Price £0.27
GF Value £0.28
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is EKF Diagnostics Holdings Cash Flow for Dividends?

EKF Diagnostics Holdings LSE:EKF +0.75% 54 Cash Flow for Dividends is £0.00 Mil as of Dec. 2025. GuruFocus rates LSE:EKF with a GF Score™ of 54/100 and a GF Value™ of £0.28 (Fairly Valued). The stock has 4 warning signs investors should review.

EKF Diagnostics Holdings's cash flow for dividends for the six months ended in Dec. 2025 was £0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was £0.00 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

EKF Diagnostics Holdings's annual payment of dividends declined from Dec. 2023 (£-5.45 Mil) to Dec. 2024 (£0.00 Mil) but then stayed the same from Dec. 2024 (£0.00 Mil) to Dec. 2025 (£0.00 Mil).

EKF Diagnostics Holdings Cash Flow for Dividends Related Terms

EKF Diagnostics Holdings Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for EKF Diagnostics Holdings's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EKF Diagnostics Holdings Cash Flow for Dividends Chart

EKF Diagnostics Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.10 -5.46 -5.45 0.00 0.00

EKF Diagnostics Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LSE:EKF
54GF Score
EKF Diagnostics Holdings PLC LSE:EKF
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EKF Diagnostics Holdings Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of £0.00 Mil mean?
EKF Diagnostics Holdings (LSE:EKF) has a Cash Flow for Dividends of £0.00 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for EKF Diagnostics Holdings and its competitors.
Is EKF Diagnostics Holdings' Cash Flow for Dividends too high?
EKF Diagnostics Holdings' current Cash Flow for Dividends is £0.00 Mil. Overall, EKF Diagnostics Holdings has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EKF Diagnostics Holdings' Cash Flow for Dividends compare to ABT and SYK?
EKF Diagnostics Holdings' Cash Flow for Dividends of £0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Devices & Instruments company?
A good Cash Flow for Dividends depends on the Medical Devices & Instruments industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for EKF Diagnostics Holdings and its competitors. EKF Diagnostics Holdings's current Cash Flow for Dividends is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EKF Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, EKF Diagnostics Holdings (LSE:EKF) is currently considered Fairly Valued. The stock's GF Value™ is £0.28, compared to a current price of £0.27 — trading 3.6% below its estimated fair value. The current Cash Flow for Dividends is £0.00 Mil. EKF Diagnostics Holdings' overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For EKF Diagnostics Holdings (LSE:EKF), the current Cash Flow for Dividends is £0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EKF Diagnostics Holdings (LSE:EKF) Overvalued in 2026?

Based on GuruFocus' analysis, EKF Diagnostics Holdings stock appears to be undervalued. The current stock price of £0.27 is trading 3.6% below its estimated GF Value™ of £0.28. GuruFocus considers EKF Diagnostics Holdings to be Fairly Valued.

Key valuation signals for LSE:EKF:

  • Cash Flow for Dividends: £0.00 Mil
  • GF Value™: £0.28 vs. price of £0.27 (3.6% below fair value)
  • GF Score™: 54/100 with 4 warning signs

No single metric tells the full story. See the LSE:EKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

EKF Diagnostics Holdings Business Description

Other Exchanges EKDHF:USALYF:Germany
Address 19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ
EKF Diagnostics Holdings PLC is engaged in development, manufacture and supply of products and services into the in-vitro diagnostic (IVD) market place. The Group has presence in the UK, USA, Germany, and Russia, and sells throughout the world including Europe, the Middle East, the Americas, Asia, and Africa. It derive their revenue from the manufacture and sale of medical diagnostic equipment and reagents. Other services include the servicing and distribution of third party company products under separate distribution agreements.
54GF Score

Get the complete analysis for LSE:EKF

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.27
Price
£0.28
GF Value